These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 2798447

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Influence of the specific antagonist of PAF-acether, BN 52021, on the rejection of murine tail skin allografts and the PAF-acether mortality in mice in particular consideration of the role of TXB2.
    Becker K, Lueddeckens G, Braquet P, Förster W.
    Prog Clin Biol Res; 1989; 301():499-503. PubMed ID: 2798460
    [No Abstract] [Full Text] [Related]

  • 5. Endotoxin shock, kinin system and PAF-acether in the rat.
    Damas J, Remacle-Volon G, Adam A, Bourdon V.
    Adv Exp Med Biol; 1989; 247B():547-52. PubMed ID: 2610092
    [No Abstract] [Full Text] [Related]

  • 6. Platelet activating factor receptor antagonist improves survival and attenuates eicosanoid release in severe endotoxemia.
    Fletcher JR, DiSimone AG, Earnest MA.
    Ann Surg; 1990 Mar; 211(3):312-6. PubMed ID: 2178565
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of rat endotoxin-induced lethality by BN 52021 and BN 52063, compounds with PAF-acether antagonistic effect and protease-inhibitory activity.
    Etienne A, Hecquet F, Guilmard C, Soulard C, Braquet P.
    Int J Tissue React; 1987 Mar; 9(1):19-26. PubMed ID: 3596954
    [Abstract] [Full Text] [Related]

  • 8. The involvement of platelet-activating factor (PAF)-induced monocyte activation and tumor necrosis factor (TNF) production in shock.
    Bonavida B, Paubert-Braquet M, Hosford D, Braquet P.
    Prog Clin Biol Res; 1989 Mar; 308():485-9. PubMed ID: 2780710
    [No Abstract] [Full Text] [Related]

  • 9. Proofs of involvement of PAF-acether in various immune disorders using BN 52021 (ginkgolide B): a powerful PAF-acether antagonist isolated from Ginkgo biloba L.
    Braquet P.
    Adv Prostaglandin Thromboxane Leukot Res; 1986 Mar; 16():179-98. PubMed ID: 2949548
    [No Abstract] [Full Text] [Related]

  • 10. Effect of PAF-antagonists in endotoxin shock--ovine and rat experiments.
    Bahrami S, Redl H, Thurnher M, Vogl C, Paul E, Schiesser A, Schlag G.
    Prog Clin Biol Res; 1989 Mar; 308():931-6. PubMed ID: 2780740
    [No Abstract] [Full Text] [Related]

  • 11. PAF-induced amplification of mediator release in septic shock: prevention or downregulation by PAF antagonists.
    Koltai M, Hosford D, Braquet P.
    J Lipid Mediat; 1993 Mar; 6(1-3):183-98. PubMed ID: 8357981
    [No Abstract] [Full Text] [Related]

  • 12. Release of eicosanoids in rat peritoneal cavity stimulated with platelet-activating factor (PAF). Effect of the PAF-antagonist BN-52021.
    Jancar S, Braquet P, Sirois P.
    Prostaglandins Leukot Essent Fatty Acids; 1989 Jul; 37(1):23-4. PubMed ID: 2548218
    [Abstract] [Full Text] [Related]

  • 13. Chemotactic effect of PAF-acether on peritoneal eosinophils from normal rats.
    Martins MA, Etienne A, Soulard C, Domingo MT, Braquet P.
    Braz J Med Biol Res; 1989 Jul; 22(9):1151-4. PubMed ID: 2636011
    [Abstract] [Full Text] [Related]

  • 14. In vivo inhibition of plasma protein leakage and Salmonella enteritidis-induced mortality in the rat by a specific paf-acether antagonist: BN 52021.
    Etienne A, Hecquet F, Soulard C, Spinnewyn B, Clostre F, Braquet P.
    Agents Actions; 1986 Jan; 17(3-4):368-70. PubMed ID: 3515870
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological control of the in vivo passive anaphylactic shock by the PAF-acether antagonist compound BN 52021.
    Vilain B, Lagente V, Touvay C, Desquand S, Randon J, Lefort J, Braquet P, Vargaftig BB.
    Pharmacol Res Commun; 1986 Aug; 18 Suppl():119-26. PubMed ID: 3774840
    [Abstract] [Full Text] [Related]

  • 16. Platelet-activating factor antagonists treatment protects against postischemic acute renal failure in rats.
    López-Farré A, Bernabeu F, Gómez-Garre D, Ramon y Cajal S, Braquet P, López-Novoa JM.
    J Pharmacol Exp Ther; 1990 Apr; 253(1):328-33. PubMed ID: 2329516
    [Abstract] [Full Text] [Related]

  • 17. Influence of platelet activating factor antagonists on the protamine sulphate stimulated release of histamine from peritoneal mast cells of rats in vitro.
    Lohde C, Bahr T, Labes D, Grupe R.
    Arzneimittelforschung; 1992 Jan; 42(1):27-31. PubMed ID: 1375025
    [Abstract] [Full Text] [Related]

  • 18. Myoelectric intestinal disturbances in Escherichia coli endotoxic shock in rats. Involvement of platelet-activating factor.
    Pons L, Droy-Lefaix MT, Braquet P, Buéno L.
    Lipids; 1991 Dec; 26(12):1359-61. PubMed ID: 1819734
    [Abstract] [Full Text] [Related]

  • 19. Influence of aminophylline and ketotifen in comparison to the lipoxygenase inhibitors NDGA and esculetin and the PAF antagonists WEB 2170 [correction of 2107] and BN 52021 on endothelin-1 induced vaso- and bronchoconstriction.
    Lueddeckens G, Becker K, Rappold R, Förster W.
    Prostaglandins Leukot Essent Fatty Acids; 1991 Nov; 44(3):155-8. PubMed ID: 1808625
    [Abstract] [Full Text] [Related]

  • 20. PAF-acether and endotoxin display similar effects on rat mesenteric microvessels: inhibition by specific antagonists.
    Lagente V, Fortes ZB, Garcia-Leme J, Vargaftig BB.
    J Pharmacol Exp Ther; 1988 Oct; 247(1):254-61. PubMed ID: 3171975
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.